Smith Group Asset Management’s Kite Pharma, Inc. KITE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-9,860
| Closed | -$1.02M | – | 490 |
|
|
2017
Q2 | $1.02M | Buy |
9,860
+2,920
| +42% | +$303K | 0.03% | 166 |
|
|
2017
Q1 | $545K | Sell |
6,940
-194
| -3% | -$15.2K | 0.02% | 181 |
|
|
2016
Q4 | $316K | Buy |
7,134
+98
| +1% | +$4.34K | 0.01% | 219 |
|
|
2016
Q3 | $391K | Buy |
7,036
+86
| +1% | +$4.78K | 0.01% | 198 |
|
|
2016
Q2 | $348K | Sell |
6,950
-100
| -1% | -$5.01K | 0.01% | 208 |
|
|
2016
Q1 | $324K | Sell |
7,050
-80
| -1% | -$3.68K | 0.01% | 176 |
|
|
2015
Q4 | $439K | Buy |
+7,130
| New | +$439K | 0.01% | 207 |
|